Classes
Publications
- Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits2013 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity2011 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Early detection of anthracycline cardiotoxicity in a rabbit model: left ventricle filling pattern versus troponin T determination2007 | Publication without faculty affiliation
- Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopyathy: A useful tool for assessment of cardioprotective agents2007 | Publication without faculty affiliation
- Hydrophobicity-enhanced ferritin nanoparticles for efficient encapsulation and targeted delivery of hydrophobic drugs to tumor cells2023 | Faculty of Pharmacy in Hradec Králové
- Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up2022 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine2022 | Faculty of Pharmacy in Hradec Králové
- Structure-Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase II beta Interactions2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
Loading network view...